Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$410,676
+$16,585 QoQ
Shares Held
1,632
-9.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#3,349
of 4,150 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Scarborough Advisors, LLC holds $1,515,832 across 3 Drug Manufacturers - General names. ABBV ranks #2 (27.1% of the industry book) .
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $410,676 | 1,632 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $394,091 | 1,812 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $396,201 | 1,734 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $398,480 | 1,721 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $316,853 | 1,707 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $344,450 | 1,644 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $278,989 | 1,570 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $218,610 | 1,107 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $189,186 | 1,103 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $198,671 | 1,091 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $163,958 | 1,058 | Shares | Sole | 2024-02-29 | |
| No filing history on record for this holder in this stock. | ||||||